Trials / Conditions / Bacterial Infections and Mycoses

Bacterial Infections and Mycoses

10 registered clinical trials studyying Bacterial Infections and Mycoses.

Status	Trial	Sponsor	Phase
Active Not Recruiting	A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women NCT06592586	Minervax ApS	Phase 2 / Phase 3
Completed	Metagenomic Sequencing in Clinical Infectious Diseases NCT05353634	Liaocheng People's Hospital	—
Completed	Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants NCT02079298	Anders Rane, MD, PhD, Senior professor	Phase 4
Completed	Iron Homoeostasis in Inflammation NCT02155114	University Hospital, Basel, Switzerland	—
Completed	Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure NCT01968395	Erasme University Hospital	Phase 4
Completed	Infant Antibiotic Resistance and Implications for Therapeutic Decision-making NCT01781182	University Hospitals Cleveland Medical Center	—
Terminated	A Study in Sepsis Patients With Renal Failure NCT00511186	AM-Pharma	Phase 2
Completed	Safety of a Single Dose of 5 mg of hLF1-11 Given to Autologous Haematopoietic Stem Cell Transplant Recipients NCT00509938	AM-Pharma	Phase 1 / Phase 2
Completed	Doripenem in the Treatment of Complicated Intra-Abdominal Infections NCT00229060	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	Doripenem in the Treatment of Complicated Intra-Abdominal Infections NCT00210938	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3